Vitamin C and Zinc: study protocols
71 study groups took Vitamin C together with Zinc. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Vitamin C
71 study groups in 60 studies say how much Vitamin C participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 100 mg to 250 mg, 37% of 71 study groups.
| Daily dose | Study groups |
|---|---|
| 25 mg or less | 2 |
| 25 mg to 50 mg | 10 |
| 50 mg to 100 mg | 6 |
| 100 mg to 250 mg | 26 |
| 250 mg to 500 mg | 22 |
| 500 mg to 1 g | 3 |
| over 1 g | 2 |
Dose per serving from research: Zinc
71 study groups in 60 studies say how much Zinc participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 10 mg to 25 mg, 38% of 71 study groups.
| Daily dose | Study groups |
|---|---|
| 2.5 mg or less | 1 |
| 2.5 mg to 5 mg | 8 |
| 5 mg to 10 mg | 7 |
| 10 mg to 25 mg | 27 |
| 25 mg to 50 mg | 12 |
| 50 mg to 100 mg | 14 |
| over 100 mg | 2 |
Commonly used together
70 of 71 study groups took Vitamin C and Zinc with something else. Shown: what 3 or more different studies gave. The 10 most common of 16.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Vitamin E | 53 |
| Beta-Carotene | 32 |
| Selenium | 27 |
| Copper | 15 |
| Vitamin A | 12 |
| Iron | 11 |
| Vitamin B12 | 8 |
| Vitamin B6 | 8 |
| Folic Acid | 7 |
| Magnesium | 7 |
71 study groups
| Study | ||||
|---|---|---|---|---|
| Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial 2021 · Zinc & vitamin C · Men aged 21–60 living in a high-exposure migrant-worker dormitory in Singapore, without known COVID-19 at enrollment | 500 mg | 80 mg | 6 weeks | 634 |
| Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males 2010 · multi-vitamin/mineral · Healthy males aged 30–55 years in full-time employment | 500 mg | 10 mg | 33 days | 103 |
| Impact of iron fortification on anaemia and iron deficiency among pre-school children living in Rural Ghana 2021 · non-iron MNP group · Children aged 6–35 months living in rural Ghana; children with severe anaemia, severe malnutrition, recent iron supplementation, or chronic disease were excluded. | 30 mg | 5 mg | 150 days | 991 |
| Fortifying milk with ferrous gluconate and zinc oxide in a public nutrition program reduced the prevalence of anemia in toddlers 2006 · Fortified milk (FM) · Healthy, low-income children aged 10–30 months | 48 mg | 5.28 mg | 26 weeks | — |
| Impact of iron fortification on anaemia and iron deficiency among pre-school children living in Rural Ghana 2021 · iron-MNP group · Children aged 6–35 months living in rural Ghana; children with severe anaemia, severe malnutrition, recent iron supplementation, or chronic disease were excluded. | 30 mg | 5 mg | 150 days | 967 |
| Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial 2007 · fortified milk · Children aged 1–3 years in a peri-urban settlement in north India | 40.2 mg | 7.8 mg | 1 year | 316 |
| Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial 2013 · active compound · Patients who had undergone polypectomy and were undergoing post-polypectomy endoscopic follow-up | 180 mg | 30 mg | 5 years | 164 |
| Megadose vitamins in bladder cancer: a double-blind clinical trial 1994 · megadose vitamins arm · Patients with biopsy-confirmed transitional cell carcinoma of the bladder receiving BCG immunotherapy | 2 g | 90 mg | — | 35 |
| "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants 1999 · antioxidant vitamins and minerals supplementation · Women aged 35 to 60 years and men aged 45 to 60 years, without a stated condition | 120 mg | 20 mg | 8 years | — |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 500 mg | 80 mg | 8 years | — |
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 50 mg | 20 mg | 335 days | — |
| Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal 2003 · Multiple micronutrients · Pregnant women in rural Nepal | 100 mg | 30 mg | — | — |
| Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 2004 · antioxidants plus zinc · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility | 500 mg | 80 mg | 339 weeks | — |
| The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals 2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population | 120 mg | 20 mg | 2739 days | — |
| Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels? 2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 120 mg | 20 mg | 2739 days | — |
| [The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health] 2006 · antioxidant supplementation · Middle-aged adults in the general population | 120 mg | 20 mg | 2738 days | — |
| Antioxidant supplementation increases the risk of skin cancers in women but not in men 2007 · antioxidant group · French adult women and men in a general-population primary-prevention trial | 120 mg | 20 mg | 2738 days | — |
| Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study 2010 · antioxidant supplementation · French women aged 35–60 years and men aged 45–60 years | 120 mg | 20 mg | 2738 days | — |
| Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 2013 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4) | 500 mg | 80 mg | 339 weeks | — |
| No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 2014 · antioxidants plus zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years | 500 mg | 80 mg | 9 years | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · combination of trace elements and vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C, zinc and selenium were common at baseline | 120 mg | 20 mg | 2 years | — |
| Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial 2015 · supplemented group · Adults with facioscapulohumeral muscular dystrophy (FSHD) | 500 mg | 25 mg | 17 weeks | 26 |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MV · Patients with type 2 diabetes | 200 mg | 20 mg | 120 days | — |
| Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial 2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering | 40.2 mg | 7.8 mg | 1 year | 316 |
| Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: A prospective, randomized, double-blind multicenter study 2024 · Treatment group · Adults younger than 60 years with COVID-19 or COVID-like illness, no previous medical history, and not hospitalized | 40 mg | 25 mg | — | 82 |
| A Collagen Supplement Improves Skin Hydration, Elasticity, Roughness, and Density: Results of a Randomized, Placebo-Controlled, Blind Study 2019 · verum group · Women aged 35–73 with healthy skin | 80 mg | 3 mg | 12 weeks | 36 |
| Dietary Intervention With a Targeted Micronutrient Formulation Reduces the Visual Discomfort Associated With Vitreous Degeneration 2021 · active group · Adults aged 18 years and older with primary age-related or myopia-related vitreous floaters | 40 mg | 5 mg | 26 weeks | 31 |
| A Dermonutrient Containing Special Collagen Peptides Improves Skin Structure and Function: A Randomized, Placebo-Controlled, Triple-Blind Trial Using Confocal Laser Scanning Microscopy on the Cosmetic Effects and Tolerance of a Drinkable Collagen Supplement 2020 · test product (Elasten) · Women aged 40–70 years; healthy, without a stated skin disease | 80 mg | 3 mg | 12 weeks | 30 |
| The Effect of a Multivitamin and Mineral Supplement on Immune Function in Healthy Older Adults: A Double-Blind, Randomized, Controlled Trial 2020 · Redoxon® Vita Immune (MVM) · Healthy men and women aged 55–75 years | 1 g | 10 mg | 12 weeks | 21 |
| Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year 2008 · treated AMD (T-AMD) group · Patients with nonadvanced age-related macular degeneration; mean age 69.4 years | 180 mg | 22.5 mg | 1 year | 15 |
| Effects of Macuprev(®) Supplementation in Age-Related Macular Degeneration: A Double-Blind Randomized Morpho-Functional Study Along 6 Months of Follow-Up 2019 · AMD-M group · Adults with intermediate age-related macular degeneration; 9 male and 21 female enrolled overall, mean age 69.32 years | 160 mg | 16 mg | 26 weeks | 15 |
| Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomised controlled trial 2005 · Standard diet plus two high-protein/energy supplements containing additional arginine, vitamin C and zinc · Inpatients aged 37–92 years with stage 2, 3 or 4 pressure ulcers | 500 mg | 30 mg | 3 weeks | — |
| Changes in ventilatory threshold at high altitude: effect of antioxidants 2006 · antioxidant (AO) supplement group · Physically fit males aged 25 ± 5 years exposed to high altitude at 4300 m | 500 mg | 30 mg | 5 weeks | — |
| Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation 2011 · Group MVB · Patients with type 2 diabetes | 200 mg | 20 mg | 120 days | — |
| French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial 2011 · antioxidant supplementation · French adults aged 45–60 years enrolled in the SU.VI.MAX study | 120 mg | 20 mg | 2922 days | — |
| The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes 2004 · group MV · People with type 2 diabetes; age and sex not reported | 200 mg | 30 mg | 90 days | 17 |
| Combination oral antioxidant supplementation reduces blood pressure 1997 · antioxidants · Hypertensive and normotensive adult outpatients; 21 were attending for hypertension treatment and 17 were normotensive outpatients with minor gastrointestinal complaints. | 500 mg | 200 mg | 8 weeks | — |
| The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes 2004 · group MV · Adults with type 2 diabetes; age and sex not reported | 200 mg | 30 mg | 90 days | 17 |
| Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled Study 2018 · VMP (Nutrilite Double X™) · Generally healthy adults aged 40–70 years in Moscow with low habitual recommended-food intake (recommended food score <12), predominantly women; no chronic diseases | 180 mg | 6 mg | 8 weeks | 60 |
| Trace element supplementation in hemodialysis patients: a randomized controlled trial 2015 · medium dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease | 100 mg | 50 mg | 180 days | 52 |
| Trace element supplementation in hemodialysis patients: a randomized controlled trial 2015 · low dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease | 100 mg | 25 mg | 180 days | 47 |
| Micronutrient deficiency in obese subjects undergoing low calorie diet 2012 · LCD intervention group (low-calorie formula diet) · Adults with obesity (BMI ≥30 kg/m²), men and women; age approximately 47 years on average | 100 mg | 15 mg | 12 weeks | 32 |
| High 15-F2t-Isoprostane Levels in Patients with a Previous History of Nonmelanoma Skin Cancer: The Effects of Supplementary Antioxidant Therapy 2015 · supplemented group · Adults aged 20 years or older with a previous history of nonmelanoma skin cancer treated by surgery | 500 mg | 50 mg | 60 days | 26 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · softgel half-dose (single softgel) · Healthy adults aged 18–45 years, women and men | 226 mg | 34.8 mg | 1 day | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · softgel full-dose (two softgels) · Healthy adults aged 18–45 years, women and men | 452 mg | 69.6 mg | 1 day | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · tablet full-dose (four tablets) · Healthy adults aged 18–45 years, women and men | 452 mg | 69.6 mg | 1 day | 15 |
| Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin 2007 · zinc group · Patients with chronic hepatitis C receiving pegylated interferon alpha-2b and ribavirin therapy | 600 mg | 150 mg | 48 weeks | 11 |
| Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study 2001 · Antioxidant supplementation group · Women aged 35–60 years and men aged 45–60 years in France, general population | 120 mg | 20 mg | 2 years | — |
| Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation 2003 · micronutrient supplement group · Alcohol-dependent patients aged 20 to 60 years without severe liver disease, hospitalized for alcohol rehabilitation | 120 mg | 20 mg | 3 weeks | — |
| Short-term daily or weekly administration of micronutrient Sprinkles has high compliance and does not cause iron overload in Chinese schoolchildren: a cluster-randomised trial 2006 · daily group · Children aged 3–6 years in a kindergarten in northern China | 50 mg | 5 mg | 13 weeks | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · VT (vitamins associated with trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 120 mg | 20 mg | 26 weeks | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · mineral and vitamin group · Hospitalized adults older than 65 years; baseline deficiencies of vitamin C, zinc and selenium were common | 120 mg | 20 mg | 2 years | — |
| Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX 1997 · trace elements associated with vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care | 120 mg | 20 mg | 1 year | — |
| Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects 1998 · supplementation group · Adult men aged 45–60 years and women aged 35–60 years | 120 mg | 20 mg | 26 weeks | — |
| Micronutrient Sprinkles reduce anemia among 9- to 24-mo-old children when delivered through an integrated health and nutrition program in rural Haiti 2007 · Sprinkles-WSB (S-WSB) · Children aged 9–24 months in rural Haiti receiving take-home fortified wheat-soy blend rations | 30 mg | 5 mg | 60 days | 254 |
| Effect of daily and weekly micronutrient supplementation on micronutrient deficiencies and growth in young Vietnamese children 1999 · daily group · children aged 6–24 months in Vietnam | 20 mg | 5 mg | 90 days | 55 |
| Effect of daily and weekly micronutrient supplementation on micronutrient deficiencies and growth in young Vietnamese children 1999 · weekly group · children aged 6–24 months in Vietnam | 2.86 mg | 2.43 mg | 90 days | 54 |
| Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study 2022 · TG1 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions | 135 mg | 7.5 mg | 12 weeks | 30 |
| Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study 2022 · TG2 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions | 270 mg | 15 mg | 6 weeks | 30 |
| Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes 2005 · group MV · Patients with type 2 diabetes; age range and sex not specified | 200 mg | 30 mg | 90 days | 17 |
| Oxidative stress in humans during work at moderate altitude 1999 · antioxidant mixture group · U.S. Marines engaged in moderate-altitude cold-weather field training; age and sex not reported | 500 mg | 30 mg | 4 weeks | 15 |
| Multinutrient Supplementation Increases Collagen Synthesis during Early Wound Repair in a Randomized Controlled Trial in Patients with Inguinal Hernia 2020 · multinutrient group · Men scheduled for Lichtenstein inguinal hernia repair; mean age 55.2 years, with inguinal hernia disease | 1.25 g | 55 mg | 4 weeks | 10 |
| Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training 1999 · antioxidant supplement (S) group · US Marine Corps volunteers undergoing 14 days of winter training at approximately 2700 m | 500 mg | 30 mg | 2 weeks | — |
| Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study 2005 · antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 120 mg | 20 mg | 2738 days | — |
| Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration 2007 · antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration | 500 mg | 80 mg | 2433 days | — |
| Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial 2010 · antioxidant micronutrient combination · Patients with a history of sporadic colorectal adenoma; age and sex not specified | 1 g | 60 mg | 120 days | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS antioxidants plus zinc · Adults aged 55–80 with early or more advanced age-related macular degeneration | 500 mg | 80 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 500 mg | 80 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation without β-carotene · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 500 mg | 80 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 500 mg | 25 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation without β-carotene and with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 500 mg | 25 mg | 5 years | — |